Op Ed: Beware the Perils of Over-Regulation for ICOs

By cineramaSeptember 6, 2017ICO

OPINION Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg […]

Click here to view full article

Disclaimer

The statements, opinions and data contained on this site are solely those of the individual authors and contributors and not of the publisher of www.bitcoinisle.com. All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured primarily from third party sources. We make no warranties of any kind in relation to our content and services, including but not limited to accuracy, security and updatedness. No part of the content and services that we provide constitutes financial advice, legal advice or any other form of advice. Any use or reliance on our content and services is solely at your own risk and discretion. You should conduct your own research, review, analyze and verify our content and services before relying on or using them. Participating in cryptocurrency activities is a highly risky endeavor, please therefore consult your financial advisor before making any monetary decisions. No content on our Site is meant to be a solicitation or offer.

Op Ed: Beware the Perils of Over-Regulation for ICOs

Tags:

Breaking News…

Previous PostChina's Exchanges Yank Token Listings Amid ICO Ban Fallout

Next PostHong Kong Securities And Futures Commission Releases Statement On Token Offerings

Leave a Reply

Disclaimer